Skip to main content

Table 2 Model parameters

From: Cost-effectiveness of preemptive skin treatment to prevent skin-toxicity caused by panitumumab in third-line therapy for KRAS wild type metastatic colorectal cancer in Japan

Parameters Base case Standard error 95% Confidence interval
Time to skin-toxicity (Preemptive)
 Shape 1.851 0.216 1.427 2.275
 Scale 0.106 0.037 0.034 0.178
Time to skin-toxicity (Reactive)
 Shape 1.082 0.120 0.847 1.318
 Scale 0.379 0.084 0.215 0.543
Progression-free survival
 Shape 1.233 0.092 1.054 1.413
 Scale 0.137 0.029 0.081 0.194
Overall survival
 Shape 1.198 0.967 1.009 1.388
 Scale 0.479 0.143 0.020 0.076